Hepatitis C virus infection and coronary artery disease risk: A systematic review of the literature

Digestive Diseases and Sciences

Volumn 59, Issue 7, 2014, Pages 1586-1593

  Wong, Robert J ^a   Kanwal, Fasiha ^b   Younossi, Zobair M ^c   Ahmed, Aijaz ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Ischemic heart disease; Myocardial infarction

Indexed keywords

ATHEROSCLEROSIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; HEART DISEASE; HEART INFARCTION; HEPATITIS C; HUMAN; INFECTION RISK; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HEART FAILURE; HEPATITIS C; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 84903477412     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3222-3     Document Type: Review

References (31)

1. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis. 2000;20:1-16. (Pubitemid 30421405)
2. Roed T, Lebech AM, Kjaer A, et al. Hepatitis C virus infection and risk of coronary artery disease: a systematic review of the literature. Clin Physiol Funct Imaging. 2012;32:421-430.
3. Amin J, Law MG, Bartlett M, et al. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368:938-945. (Pubitemid 44331386)
4. Kiechl S, Egger G, Mayr M, et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation. 2001;103:1064-1070. (Pubitemid 32200178)
5. Volzke H, Schwahn C, Wolff B, et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004;174:99-103. (Pubitemid 38595446)
6. Guiltinan AM, Kaidarova Z, Custer B, et al. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol. 2008;167:743-750. (Pubitemid 351430942)
7. Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intimamedia thickening. Lancet. 2002;359:133-135. (Pubitemid 34112545)
8. Butt AA, Xiaoqiang W, Budoff M, et al. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009;49:225-232.
9. Alyan O, Kacmaz F, Ozdemir O, et al. Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system. Circ J. 2008;72: 1960-1965.
10. Vassalle C, Masini S, Bianchi F, et al. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart. 2004;90:565-566. (Pubitemid 38530180)
11. Younossi ZM, Stepanova M, Nader F, et al. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther. 2013;37:647-652.
12. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358-1364. (Pubitemid 32496971)
13. Adinolfi LE, Restivo L, Zampino R, et al. Chronic HCV infection is a risk for atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis. 2012;221:496-502.
14. Volzke H, Robinson DM, Kleine V, et al. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol. 2005;11:1848-1853. (Pubitemid 40520783)
15. Gastaldelli A, Kozakova M, Højlund K, RISC Investigators, et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology. 2009;49:1537-1544.
16. Sanyal AJ, Contos MJ, Sterling RK, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. Am J Gastroenterol. 2003;98:2064-2071. (Pubitemid 37185807)
17. Sanyal AJ. Review article: non-alcoholic fatty liver disease and hepatitis C - risk factors and clinical implications. Aliment Pharmacol Ther. 2005;22:48-51. (Pubitemid 41564383)
18. Targher G, Bertolini L, Scala L, et al. Nonalcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men: role of visceral adipose tissue. Diabet Med. 2005;22:1354-1358. (Pubitemid 41391311)
19. Marzouk D, Sass J, Bakr I, et al. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007;56:1105-1110. (Pubitemid 47123241)
20. Corey KE, Kane E, Munroe C, et al. Hepatitis C virus infection and its clearance alter circulating lipids: implications for longterm follow-up. Hepatology. 2009;50:1030-1037.
21. Bilora F, Rinaldi R, Boccioletti V, et al. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol. 2002;26:1001-1004. (Pubitemid 35440173)
22. Butt AA, Khan UA, McGinnis KA, et al. Co-morbid medical and psychiatric illness and substance abuse in HCV-infected and uninfected veterans. J Viral Hepatitis. 2007;14:890-896. (Pubitemid 350211412)
23. Moher D, Liberati A, Tetzlaff J, PRISMA Group, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269.
24. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in metaanalyses. Eur J Epidemiol. 2010;25:603-605.
25. Forde KA, Haynes K, Troxel AB, et al. Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study. J Viral Hepat. 2012;19:271-277.
26. Arcari CM, Nelson KE, Netski DM, et al. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis. 2006;43:e53-e56.
27. Maruyama S, Koda M, Oyake N, et al. Myocardial injury in patients with chronic hepatitis C infection. J Hepatol. 2013;58: 11-15.
28. Miyajima I, Kawaguchi T, Fukami A, et al. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J Gastroenterol. 2013;48:93-100.
29. Oliveira CP, Kappel CR, Siqueira ER, et al. Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol. 2013;164:221-226.
30. Fukui M, Kitagawa Y, Nakamura N, et al. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA. 2003; 289:1245-1246. (Pubitemid 37432904)
31. Boddi M, Abbate R, Chellini B, et al. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol. 2010;47:72-75.